Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta-analysis.

Ahmed N HassanAaron S HoweAndriy V SamokhvalovBernard Le FollTony P George

Published in: The American journal on addictions (2017)

To date, psychotherapy has the most documented evidence for efficacy. TCAs appears effective but with more adverse effects than SSRIs. Further studies of OAT and adjunct antidepressant treatments for dual diagnosis patients are warranted. (Am J Addict 2017;26:551-563).

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
chronic pain
bipolar disorder
pain management
peritoneal dialysis
mesenchymal stem cells
physical activity
patient reported outcomes
depressive symptoms
sleep quality
replacement therapy